Acute heart failure (AHF) is a life-threatening condition with poor prognosis. Gender differences have been increasingly recognized in diverse cardiovascular diseases. The present study aimed to evaluate gender-specific prognostic markers of all-cause death in AHF patients based on a prospective 18-month follow-up study. Data were collected from 419 patients with AHF hospitalization who were followed up for 18 months using all-cause death as primary endpoint. The mean age of all patients was 60.9 ± 15.7 years old, 277 were males, and 142 were females. Females had higher rate of valvular heart disease (37.3%) and atrial fibrillation (45.8%) but lower rate of cardiomyopathy (30.3%) than males in this cohort. Based on multiple COX stepwise regression and ROC curve analysis, diastolic blood pressure (DBP), serum sodium, serum creatinine, and pulmonary artery systolic pressure (PASP) were identified as independent predictors of all-cause death in male AHF patients, while systolic blood pressure (SBP), serum aspartate transaminase (AST), serum creatinine, and serum D-dimer as independent predictors in females. Kaplan-Meier analysis showed a higher probability of all-cause death over time in male AHF patients with DBP ≤ 77 mmHg, serum sodium ≤ 138.5 mM, serum creatinine ≥ 126.2 μM, or PASP ≥ 52 mmHg, and in female AHF patients with SBP ≤ 129 mmHg, serum AST > 29.3 U/L, serum creatinine ≥ 102.7 μM, or serum D-dimer ≥ 1.76 mg/L. In conclusion, these data provide novel insights into gender differences in prognostic markers of outcomes of AHF patients.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G., Coats, A. J., et al. (2016). 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 18(8), 891–975.
Mosterd, A., & Hoes, A. W. (2007). Clinical epidemiology of heart failure. Heart, 93(9), 1137–1146.
Kurmani, S., & Squire, I. (2017). Acute heart failure: definition, classification and epidemiology. Current Heart Failure Reports, 14(5), 385–392.
Adams, K. F., Jr., Fonarow, G. C., Emerman, C. L., LeJemtel, T. H., Costanzo, M. R., Abraham, W. T., et al. (2005). Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). American Heart Journal, 149(2), 209–216.
Gheorghiade, M., Zannad, F., Sopko, G., Klein, L., Pina, I. L., Konstam, M. A., et al. (2005). Acute heart failure syndromes: current state and framework for future research. Circulation, 112(25), 3958–3968.
Wang, L., Lv, Y., Li, G., & Xiao, J. (2018). MicroRNAs in heart and circulation during physical exercise. Journal of Sport and Health Science, 7(4), 433–441.
Rahimi, K., Bennett, D., Conrad, N., Williams, T. M., Basu, J., Dwight, J., et al. (2014). Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Failure, 2(5), 440–446.
Pocock, S. J., Ariti, C. A., McMurray, J. J., Maggioni, A., Kober, L., Squire, I. B., et al. (2013). Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. European Heart Journal, 34(19), 1404–1413.
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Jr., Colvin, M. M., et al. (2017). 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. Journal of the American College of Cardiology, 70(6), 776–803.
Chodick, G., Weitzman, D., Blaustein, R. O., Shalev, V., & Bash, L. D. (2017). Differences in short and long-term survival between males and females with new-onset heart failure: a retrospective cohort study. European Journal of Internal Medicine, 41, e21–e23.
Bleumink, G. S., Knetsch, A. M., Sturkenboom, M. C., Straus, S. M., Hofman, A., Deckers, J. W., et al. (2004). Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure the Rotterdam study. European Heart Journal, 25(18), 1614–1619.
Stein, G. Y., Ben-Gal, T., Kremer, A., Bental, T., Alon, D., Korenfeld, R., et al. (2013). Gender-related differences in hospitalized heart failure patients. European Journal of Heart Failure, 15(7), 734–741.
Nieminen, M. S., Harjola, V. P., Hochadel, M., Drexler, H., Komajda, M., Brutsaert, D., et al. (2008). Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. European Journal of Heart Failure, 10(2), 140–148.
Gustafsson, F., Torp-Pedersen, C., Burchardt, H., Buch, P., Seibaek, M., Kjoller, E., et al. (2004). Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure. European Heart Journal, 25(2), 129–135.
Vaartjes, I., Hoes, A. W., Reitsma, J. B., de Bruin, A., Grobbee, D. E., Mosterd, A., et al. (2010). Age- and gender-specific risk of death after first hospitalization for heart failure. BMC Public Health, 10, 637.
Conde-Martel, A., Arkuch, M. E., Formiga, F., Manzano-Espinosa, L., Aramburu-Bodas, O., Gonzalez-Franco, A., et al. (2015). Gender related differences in clinical profile and outcome of patients with heart failure. Results of the RICA Registry. Revista Clínica Española, 215(7), 363–370.
Stramba-Badiale, M., Fox, K. M., Priori, S. G., Collins, P., Daly, C., Graham, I., et al. (2006). Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. European Heart Journal, 27(8), 994–1005.
Sherwood, A., Hill, L. K., Blumenthal, J. A., Adams, K. F., Jr., Paine, N. J., Koch, G. G., et al. (2017). Blood pressure reactivity to psychological stress is associated with clinical outcomes in patients with heart failure. American Heart Journal, 191, 82–90.
Meng, F. C., Li, Y. H., Lin, G. M., Lin, C. S., Yang, S. P., & Lin, W. H. (2018). Association of preexisting hypertension with the morality in patients with systolic heart failure in Taiwan: the TSOC-HFrEF registry. Indian Heart Journal, 70(5), 604–607.
Segal, O., Segal, G., Leibowitz, A., Goldenberg, I., Grossman, E., & Klempfner, R. (2017). Elevation in systolic blood pressure during heart failure hospitalization is associated with increased short and long-term mortality. Medicine (Baltimore), 96(5), e5890.
Schmid, F. A., Schlager, O., Keller, P., Seifert, B., Huang, R., Frohlich, G. M., et al. (2017). Prognostic value of long-term blood pressure changes in patients with chronic heart failure. European Journal of Heart Failure, 19(7), 837–842.
Klein, L., O'Connor, C. M., Leimberger, J. D., Gattis-Stough, W., Pina, I. L., Felker, G. M., et al. (2005). Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the outcomes of a prospective trial of intravenous Milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study. Circulation, 111(19), 2454–2460.
Rusinaru, D., Tribouilloy, C., Berry, C., Richards, A. M., Whalley, G. A., Earle, N., et al. (2012). Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(dagger): Meta-analysis Global Group in Chronic heart failure (MAGGIC). European Journal of Heart Failure, 14(10), 1139–1146.
Gheorghiade, M., Abraham, W. T., Albert, N. M., Gattis Stough, W., Greenberg, B. H., O'Connor, C. M., et al. (2007). Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. European Heart Journal, 28(8), 980–988.
Cappola, T. P., Felker, G. M., Kao, W. H., Hare, J. M., Baughman, K. L., & Kasper, E. K. (2002). Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation, 105(14), 1663–1668.
Szwejkowski, B. R., Elder, D. H., Shearer, F., Jack, D., Choy, A. M., Pringle, S. D., et al. (2012). Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study. European Journal of Heart Failure, 14(2), 162–167.
Bursi, F., McNallan, S. M., Redfield, M. M., Nkomo, V. T., Lam, C. S., Weston, S. A., et al. (2012). Pulmonary pressures and death in heart failure: a community study. Journal of the American College of Cardiology, 59(3), 222–231.
Shalaby, A., Voigt, A., El-Saed, A., & Saba, S. (2008). Usefulness of pulmonary artery pressure by echocardiography to predict outcome in patients receiving cardiac resynchronization therapy heart failure. The American Journal of Cardiology, 101(2), 238–241.
Kalogeropoulos, A. P., Siwamogsatham, S., Hayek, S., Li, S., Deka, A., Marti, C. N., et al. (2014). Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients. Journal of the American Heart Association, 3(1), e000363.
Damy, T., Goode, K. M., Kallvikbacka-Bennett, A., Lewinter, C., Hobkirk, J., Nikitin, N. P., et al. (2010). Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. European Heart Journal, 31(18), 2280–2290.
Adamson, P. B., Abraham, W. T., Stevenson, L. W., Desai, A. S., Lindenfeld, J., Bourge, R. C., et al. (2016). Pulmonary artery pressure-guided heart failure management reduces 30-day readmissions. Circulation. Heart Failure, 9(6). https://doi.org/10.1161/CIRCHEARTFAILURE.115.002600.
Bangalore, S., Messerli, F. H., Wun, C. C., Zuckerman, A. L., DeMicco, D., Kostis, J. B., et al. (2010). J-curve revisited: An analysis of blood pressure and cardiovascular events in the treating to new targets (TNT) trial. European Heart Journal, 31(23), 2897–2908.
Group, S. P. S. S, Benavente, O. R., Coffey, C. S., Conwit, R., Hart, R. G., McClure, L. A., et al. (2013). Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet, 382(9891), 507–515.
Group, A. S, Cushman, W. C., Evans, G. W., Byington, R. P., Goff, D. C., Jr., Grimm, R. H., Jr., et al. (2010). Effects of intensive blood-pressure control in type 2 diabetes mellitus. The New England Journal of Medicine, 362(17), 1575–1585.
Ferreira, J. P., Duarte, K., Pfeffer, M. A., McMurray, J. J. V., Pitt, B., Dickstein, K., et al. (2018). Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the high-risk myocardial infarction database initiative. European Journal of Heart Failure, 20(2), 323–331.
Voors, A. A., Ouwerkerk, W., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P., et al. (2017). Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. European Journal of Heart Failure, 19(5), 627–634.
Upadhya, B., Rocco, M., Lewis, C. E., Oparil, S., Lovato, L. C., Cushman, W. C., et al. (2017). Effect of intensive blood pressure treatment on heart failure events in the systolic blood pressure reduction intervention trial. Circulation. Heart Failure, 10(4). https://doi.org/10.1161/CIRCHEARTFAILURE.116.003613.
Farag, M., Borst, T., Sabashnikov, A., Zeriouh, M., Schmack, B., Arif, R., et al. (2017). Surgery for infective endocarditis: outcomes and predictors of mortality in 360 consecutive patients. Medical Science Monitor, 23, 3617–3626.
Yoshihisa, A., Sato, Y., Yokokawa, T., Sato, T., Suzuki, S., Oikawa, M., et al. (2018). Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction. ESC Heart Failure, 5(2), 262–270.
Samsky, M. D., Patel, C. B., DeWald, T. A., Smith, A. D., Felker, G. M., Rogers, J. G., et al. (2013). Cardiohepatic interactions in heart failure: an overview and clinical implications. Journal of the American College of Cardiology, 61(24), 2397–2405.
Moller, S., & Bernardi, M. (2013). Interactions of the heart and the liver. European Heart Journal, 34(36), 2804–2811.
Nikolaou, M., Parissis, J., Yilmaz, M. B., Seronde, M. F., Kivikko, M., Laribi, S., et al. (2013). Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. European Heart Journal, 34(10), 742–749.
Zymlinski, R., Sokolski, M., Biegus, J., Siwolowski, P., Nawrocka-Millward, S., Sokolska, J. M., et al. (2018). Multi-organ dysfunction/injury on admission identifies acute heart failure patients at high risk of poor outcome. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.1378.
Cannon, J. A., McMurray, J. J., & Quinn, T. J. (2015). ‘Hearts and minds’: association, causation and implication of cognitive impairment in heart failure. Alzheimer's Research & Therapy, 7(1), 22.
Satilmisoglu, M. H., Ozyilmaz, S. O., Gul, M., Ak Yildirim, H., Kayapinar, O., Gokturk, K., et al. (2017). Predictive values of D-dimer assay, GRACE scores and TIMI scores for adverse outcome in patients with non-ST-segment elevation myocardial infarction. Therapeutics and Clinical Risk Management, 13, 393–400.
Zorlu, A., Yilmaz, M. B., Yucel, H., Bektasoglu, G., Refiker Ege, M., & Tandogan, I. (2012). Increased d-dimer levels predict cardiovascular mortality in patients with systolic heart failure. Journal of Thrombosis and Thrombolysis, 33(4), 322–328.
Bell, J. R., Curl, C. L., Harding, T. W., Vila Petroff, M., Harrap, S. B., & Delbridge, L. M. D. (2016). Male and female hypertrophic rat cardiac myocyte functional responses to ischemic stress and beta-adrenergic challenge are different. Biology of Sex Differences, 7, 32.
Hutcheon, J. A., Lisonkova, S., & Joseph, K. S. (2011). Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Practice & Research. Clinical Obstetrics & Gynaecology, 25(4), 391–403.
Hopper, I., Kotecha, D., Chin, K. L., Mentz, R. J., & von Lueder, T. G. (2016). Comorbidities in heart failure: are there gender differences? Current Heart Failure Reports, 13(1), 1–12.
Bellamy, L., Casas, J. P., Hingorani, A. D., & Williams, D. (2009). Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet, 373(9677), 1773–1779.
Chen, Y. J., Sung, S. H., Cheng, H. M., Huang, W. M., Wu, C. L., Huang, C. J., et al. (2017). Performance of AHEAD score in an Asian cohort of acute heart failure with either preserved or reduced left ventricular systolic function. Journal of the American Heart Association, 6(5). https://doi.org/10.1161/JAHA.116.004297.
This work was supported by the grants from National Natural Science Foundation of China (81730106 and 81670347 to XL Li) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD20102013 to XL Li).
Conflict of Interest
The authors declare that they have no conflict of interest.
Research Involving Human Participants and/or Animals
This study was approved by the Ethic Committee of the First Affiliated Hospital of Nanjing Medical University and registered at http://www.chictr.org/cn (Registration Number: ChiCTR-ONC-12001944). From March 2012 to October 2016, a total of 493 patients were prospectively enrolled and hospitalized for diagnosis of AHF in Cardiology Department of the First Affiliated Hospital of Nanjing Medical University, according to Chinese guidelines for the diagnosis and treatment of heart failure. Data collection included demographic characteristics, medical history, etiology and comorbidity of AHF, oral medications at admission, laboratory examination, 12-lead ECG, and echocardiography. Patients with AHF hospitalization were followed up for 18 months using all-cause death as primary endpoint.
All participants gave written informed consent in accordance with the Declaration of Helsinki.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Associate Editor Yihua Bei oversaw the review of this article
About this article
Cite this article
Wu, X., Chen, M., Wang, K. et al. Gender Differences in Prognostic Markers of All-Cause Death in Patients with Acute Heart Failure: a Prospective 18-Month Follow-Up Study. J. of Cardiovasc. Trans. Res. 13, 97–109 (2020). https://doi.org/10.1007/s12265-019-09893-2
- Acute heart failure
- All-cause death